| 000 | 05170na a2200697 4500 | ||
|---|---|---|---|
| 001 | 56069 | ||
| 003 | koha_MIRAKIL | ||
| 005 | 20221103143646.0 | ||
| 008 | 111030b tu 000 0 | ||
| 020 | _a0896034771 | ||
| 040 |
_aCY-NiCIU _btur _cCY-NiCIU _erda |
||
| 041 | _aEnglish | ||
| 082 |
_a616.042 _bT44 1998 |
||
| 245 |
_aTherapeutic applications of ribozymes _cEditor: Kevin J. Scanlon |
||
| 260 |
_aU.S.A. _bHumana Press _c1998 |
||
| 264 | 1 |
_a: _b, _c. |
|
| 300 |
_aXIV, 462 p. _btab., ill. _c23.8 cm. |
||
| 336 |
_2rdacontent _atext _btxt |
||
| 337 |
_2rdamedia _aunmediated _bn |
||
| 338 |
_2rdacarrier _avolume _bnc |
||
| 504 | _aIncludes index. (447-462 p.) | ||
| 650 | _aHastalıklar | ||
| 650 | _aDiseases | ||
| 650 | _aCatalytic RNA--Therapeutic use | ||
| 650 | _aKatalitik RNA - Tedavi amaçlı kullanım | ||
| 650 | _aCatalytic RNA--Laboratory manuals | ||
| 650 | _aKatalitik RNA - Laboratuvar kılavuzları | ||
| 700 |
_aEditor,: Scanlon,Kevin J. _d1947- |
||
| 942 |
_2ddc _cBK |
||
| 505 | 1 |
_rPhilip Hendry. Trevor J. Lockett, and Maxine J. McCall _p1 _tSmall Efficient Hammerhead Ribozymes |
|
| 505 | 1 |
_rArnold Hampel _p17 _tThe Hairpin Ribozyme: Discovery and Development for Gene Therapy |
|
| 505 | 1 |
_rN.Kyle Tanner _p29 _tMolecular Manipulations of the Catalytic RNAs From the Human Hepatitis |
|
| 505 | 1 |
_rLun-Quab Sun, Wayne Gerlach. and Geoff Symonds _p51 _tThe Design, Production , and Validation of an Anti-HIV Type 1 Ribozyme |
|
| 505 | 1 |
_rEric M. Poeschia, Mang Yu, Mark C. Leavitt. and Flossie Wong-Staal/ _p65 _tMethods For Treating HIV by Gene Therapy Using Ribozymes |
|
| 505 | 1 |
_rJun Ohkawa, Yutaka Takebe, and Kazunari Taira _p83 _tAn Expression Vector for Multiple Ribozymes |
|
| 505 | 1 |
_rGerd Hobom and Annette Menke _p97 _tViral RNA Targets for Ribozymes : Influenza A virus |
|
| 505 | 1 |
_rFritz von Welzsacker, Hubert E.Blum, and Jack R. Wands _p111 _tHammerhead Ribozyme-Mediated Cleavage of Hepatitis B Virus RNA |
|
| 505 | 1 |
_rGlenn H. Cantor _p119 _tBovine Leukemia Virus Ribozymes |
|
| 505 | 1 |
_rDavid Y. Bouffard _p131 _tUse of Ribozymes to Specifically Alter the MDR-1 Phenotype |
|
| 505 | 1 |
_rAkira Irie, Jerry Tsai, and Mohammed Kashani -Sabet _p153 _tAdenoviral-Mediated Anti-H-ras Ribozyme for the Treatment of Bladder Cancer |
|
| 505 | 1 |
_rTsukasa Ohkawa and Mohammed Kashani-Sabet _p169 _tTissue-Specific Delivery of an Anti-H-ras Ribozyme Against Malignant Melanoma |
|
| 505 | 1 |
_rHiroshi Kijima, David Y. Bouffard, and Kevin J. Scanlon _p193 _tRibozymes as a Novel Approach for the Treatment of Human Pancreatic Carcinoma |
|
| 505 | 1 |
_rAlex W. Tong, Yu-An Zhang, John Nemunaitis and Gabriele Mues _p209 _tK-ras Ribozyme for Lung Cancer |
|
| 505 | 1 |
_rToshiya Suzuki,Lisa D. Curclo, Jerry Tsai, and Mohammed Kashani-Sabet _p223 _tAnti-C-erb-B-2 Ribozyme for Breast Cancer |
|
| 505 | 1 |
_rGunhild M Maelandsmo, Inge Kjonniksen, Elvind Hovig, Kevin J.Scanlon, and Oystein Fodstad _p241 _tRibozymes: Applications in Cancer Metastasis Research |
|
| 505 | 1 |
_rMouldy Sloud _p261 _tPreformed Ribozymes: Strategies for Design and In Vivo Application as Anticytokine Agents |
|
| 505 | 1 |
_rLance H.Leopold, Scott K. Shore, Ramana M.V. Reddy and E. Premkumar Reddy _p279 _tFolate-Polysine-Mediated Delivery of a Multiunit Anti-BAR/ABL Ribozyme to BCR/ABL-Transformed 32D Cells |
|
| 505 | 1 |
_rHiromichi Matsushita, Hiroyuki Kobayashi, Masahiro Kizaki, and Yasuo Ikeda _p293 _tRibozymes Targeted Against AML1/MTG8: Evaluation of Ribozyme Efficiency in a cell-Free System and Transfection with Cationic Lipsome |
|
| 505 | 1 |
_rFrank Czubayka, Anke M.Schulte, and Anton Wellstein _p311 _tRibozyme Targeting of the Growth Factor Pleiotrophin |
|
| 505 | 1 |
_rThale C. Javis, Dennis Macejak, and Larry Couture _p329 _tRibozyme-Mediated Inhibition of Cell Proliferation : A Model for Identifying and Refining a Therapeutic Ribozyme |
|
| 505 | 1 |
_rMariyn Smedman and Robert B.Denman _p341 _tInhibition of βAPP Synthesis by Ribozymes and Oligonucleotides in a Coupled Reticulocyte Transcription Transcription Translation System |
|
| 505 | 1 |
_rJoohun Ha _p357 _tSelective Modification of Fatty Acid Synthesis Pathway by Expression of an Acetyl-CoA Carboxylase-Specific Ribozyme Gene |
|
| 505 | 1 |
_rS. Petter Lyngstadaas, Brian S Sproat, Martina Biaschke Janos Ludwig, Thomas Rupp, and Hans P. Prydz _p371 _tIn Vivo Knockout of a Tissue-Specific Gene by Synthetic Ribozymes |
|
| 505 | 1 |
_rShimon Efrat _p387 _tRibozyme-Mediated Downregulation of Gene Expression in Transgenic Mice |
|
| 505 | 1 |
_rYan Yuan and Fenyong Liu _p397 _tTargeted Cleavage of RNA Using External Guide Sequences and Eukaryotic RNase P |
|
| 505 | 1 |
_rYan Yuan _p415 _tApplication of In Vitro Selection in Design of External Guide Sequences That Direct Efficient Cleavage of RNA by RNase P |
|
| 505 | 1 |
_rKatalin Kariko and Elliot S. Barnathan _p427 _tA PCR-Based Approach to Hammerhead Ribozyme Synthesis |
|
| 505 | 1 |
_rP. Kamath and E.J.Shillitoe _p439 _tMeasurement of Ribozyme Activity Using RNase Protection |
|
| 505 | 0 |
_g447 _tIndex |
|
| 999 |
_c9111 _d9111 |
||